Latest Research Posts

Go 6976 Inhibits PKD1 to Block TLR/IL-1R Inflammatory Cascades in Arthritis
Go 6976 Inhibits PKD1 to Block TLR/IL-1R Inflammatory Cascades in Arthritis
AACOCF3 Selectively Inhibits Cytosolic Phospholipase A2 to Block Inflammatory Eicosanoid Biosynthesis
AACOCF3 Selectively Inhibits Cytosolic Phospholipase A2 to Block Inflammatory Eicosanoid Biosynthesis
Avapritinib (BLU-285) BLU285 Inhibits PDGFRA D842V Active Kinase Conformation in GIST
Avapritinib (BLU-285) BLU285 Inhibits PDGFRA D842V Active Kinase Conformation in GIST
Butyrolactone 3 from Selleck in Creatine Kinase-MB Post-PCI Risk Prediction Assessment
Butyrolactone 3 from Selleck in Creatine Kinase-MB Post-PCI Risk Prediction Assessment
Plicamycin from Selleck Suppresses Sp1-Driven Twist1 Expression in Gastric Cancer
Plicamycin from Selleck Suppresses Sp1-Driven Twist1 Expression in Gastric Cancer
Paxalisib (GDC-0084 from Selleck) Inhibits PI3K mTOR Signaling to Suppress Glioma Glycolysis
Paxalisib (GDC-0084 from Selleck) Inhibits PI3K mTOR Signaling to Suppress Glioma Glycolysis
Bisindolylmaleimide I Inhibits PKCβ-Mediated Vasoconstriction in Frozen Embryo Transfer Umbilical Veins
Bisindolylmaleimide I Inhibits PKCβ-Mediated Vasoconstriction in Frozen Embryo Transfer Umbilical Veins
GSK2656157 Inhibits PERK-eIF2α Signaling to Restore Cardioprotection in Aged Hypoxic Cardiomyocytes
GSK2656157 Inhibits PERK-eIF2α Signaling to Restore Cardioprotection in Aged Hypoxic Cardiomyocytes
Sotrastaurin (AEB071) inhibits PRKCQ kinase activity to attenuate invasive growth in TNBC
Sotrastaurin (AEB071) inhibits PRKCQ kinase activity to attenuate invasive growth in TNBC
Eprenetapopt (APR-246) APR-246 from Selleck Reactivates Mutated p53 Signaling to Reverse Venetoclax Resistance
Eprenetapopt (APR-246) APR-246 from Selleck Reactivates Mutated p53 Signaling to Reverse Venetoclax Resistance
Midostaurin (PKC412) PKC inhibitor Suppresses MYC and Overcomes Resistance in KRAS-Mutant Lung Adenocarcinoma
Midostaurin (PKC412) PKC inhibitor Suppresses MYC and Overcomes Resistance in KRAS-Mutant Lung Adenocarcinoma
Dactolisib (BEZ235) BEZ235 from Selleck Dual PI3K/mTOR Inhibition in Colorectal Cancer
Dactolisib (BEZ235) BEZ235 from Selleck Dual PI3K/mTOR Inhibition in Colorectal Cancer
Darovasertib (LXS196) selectively inhibits protein kinase C to disrupt MAPK signaling in uveal melanoma
Darovasertib (LXS196) selectively inhibits protein kinase C to disrupt MAPK signaling in uveal melanoma
Tariquidar (XR9576) P-gp inhibitor Modulation of ABCB1 Endocytosis and Cytotoxic Chemosensitivity
Tariquidar (XR9576) P-gp inhibitor Modulation of ABCB1 Endocytosis and Cytotoxic Chemosensitivity
2',3'-cGAMP Activation of cGAS STING Signaling in Host Innate Immunity
2',3'-cGAMP Activation of cGAS STING Signaling in Host Innate Immunity
AZD5305 (Saruparib) Saruparib from Selleck Demonstrates Selective PARP1 Inhibition and Target Trapping
AZD5305 (Saruparib) Saruparib from Selleck Demonstrates Selective PARP1 Inhibition and Target Trapping
NAD+ (β-DPN) Others chemical regulates sirtuin deacetylation and cellular metabolic homeostasis
NAD+ (β-DPN) Others chemical regulates sirtuin deacetylation and cellular metabolic homeostasis
Gedatolisib (PKI-587) Gedatolisib from Selleck Dual PI3K/mTOR Inhibition Reverses Cetuximab Resistance
Gedatolisib (PKI-587) Gedatolisib from Selleck Dual PI3K/mTOR Inhibition Reverses Cetuximab Resistance
4-HNE (4-Hydroxynonenal) 4-Hydroxynonenal Others chromatin autoantibodies in SLE
4-HNE (4-Hydroxynonenal) 4-Hydroxynonenal Others chromatin autoantibodies in SLE
Eganelisib from Selleck targets PI3Kγ to overcome immunogenic resistance in HNSCC models
Eganelisib from Selleck targets PI3Kγ to overcome immunogenic resistance in HNSCC models
Elacridar (GF120918) Elacridar P-gp inhibitor Reverses ABCB1 Mediated Multidrug Resistance in Cancer
Elacridar (GF120918) Elacridar P-gp inhibitor Reverses ABCB1 Mediated Multidrug Resistance in Cancer
Etomoxir Others inhibitor targeting CPT1 attenuates mitochondrial fatty acid oxidation
Etomoxir Others inhibitor targeting CPT1 attenuates mitochondrial fatty acid oxidation
Pictilisib from Selleck (GDC-0941) PI3K Pathway Inhibition in Breast Cancer
Pictilisib from Selleck (GDC-0941) PI3K Pathway Inhibition in Breast Cancer
GO-203 TFA inhibitor suppresses MUC1-C to derepress MICA/B and enhance NK cell cytotoxicity
GO-203 TFA inhibitor suppresses MUC1-C to derepress MICA/B and enhance NK cell cytotoxicity
Veliparib (ABT-888) PARP-1/2 Inhibition: Cardiac Repolarization Safety in Advanced Solid Tumors
Veliparib (ABT-888) PARP-1/2 Inhibition: Cardiac Repolarization Safety in Advanced Solid Tumors
Menadione (Vitamin K3) phosphatase inhibitor targeting cellular redox systems for cancer therapy
Menadione (Vitamin K3) phosphatase inhibitor targeting cellular redox systems for cancer therapy
3-Hydroxybutyric acid from Selleck profiling identifies diagnostic serum metabolomic biomarkers in endometriosis
3-Hydroxybutyric acid from Selleck profiling identifies diagnostic serum metabolomic biomarkers in endometriosis
CBL0137 Hydrochloride (CBL0137) Targets Chromatin Architecture via FACT Trapping
CBL0137 Hydrochloride (CBL0137) Targets Chromatin Architecture via FACT Trapping
Apilimod (STA-5326) Inhibits PIKfyve to Block SARS-CoV-2 Endosomal Viral Entry
Apilimod (STA-5326) Inhibits PIKfyve to Block SARS-CoV-2 Endosomal Viral Entry
Volasertib PLK inhibitor BI6727 attenuates pulmonary vascular remodeling via target PLK1 suppression
Volasertib PLK inhibitor BI6727 attenuates pulmonary vascular remodeling via target PLK1 suppression
Cremophor EL Formulations Enhance Brain Targeted Delivery and Inhibit P-Glycoprotein Efflux
Cremophor EL Formulations Enhance Brain Targeted Delivery and Inhibit P-Glycoprotein Efflux
ISRIB (trans-isomer) ISRIB inhibitor eIF2B modulation in stress response
ISRIB (trans-isomer) ISRIB inhibitor eIF2B modulation in stress response
Methyl-β-cyclodextrin (MβCD) Methylβcyclodextrin Disrupts MSC Membrane Rafts to Suppress PI3K/Akt Signaling
Methyl-β-cyclodextrin (MβCD) Methylβcyclodextrin Disrupts MSC Membrane Rafts to Suppress PI3K/Akt Signaling
SAR405 from Selleck Target VPS34 Autophagy Inhibition Activates STING NF-kB Pathway
SAR405 from Selleck Target VPS34 Autophagy Inhibition Activates STING NF-kB Pathway